For citations:
Verveda A.B., Vasilyuk V.B., Syraeva G.I., Faraponova M.V., Popov A.V. Implementation of quantitative integral analysis in assessing events associated with safety issues during clinical trials: focusing on trastuzumab. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2024;(4):21-34. (In Russ.) https://doi.org/10.37489/2588-0519-2024-4-21-34. EDN: ZEWDXG
Email this article 